From Nasdaq.: 2025-05-24 15:07:00

Validea’s guru fundamental report for NOVARTIS AG (ADR) (NVS) shows it rates highest using the Multi-Factor Investor model based on Pim van Vliet’s strategy. This strategy seeks low volatility stocks with strong momentum and high net payout yields. NVS is a large-cap growth stock in the Biotechnology & Drugs industry, with a rating of 87% based on fundamentals and valuation. The stock meets some criteria of the strategy, but not all. Pim van Vliet’s research into conservative factor investing shows that low volatility stocks can outperform high volatility ones with less risk. Validea is an investment research service that follows the strategies of investment legends.



Read more at Nasdaq.: NVS Quantitative Stock Analysis | Nasdaq